tiprankstipranks
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
US Market
QNRX
Quoin Pharmaceuticals
RESEARCH TOOLSreports

Quoin Pharmaceuticals (QNRX) Income Statement

379 Followers

Quoin Pharmaceuticals Income Statement

Last quarter (Q4 2025), Quoin Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Quoin Pharmaceuticals's net income was $-15.79B. See Quoin Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -100.79K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.32M$ 9.53M$ 9.38M$ 9.26M$ 6.06M
Depreciation and Amortization
$ 100.79K$ 100.00K$ 103.71K$ 104.04K$ 104.04K
EBITDA
$ -16.32M$ -9.43M$ -9.27M$ -8.56M$ -20.27M
Operating Income
$ -16.42M$ -9.53M$ -9.38M$ -9.26M$ -6.06M
Other Income/Expenses
$ 489.30K$ 565.99K$ 691.93K$ -123.79K$ -15.40M
Pretax Income
$ -15.93M$ -8.96M$ -8.69M$ -9.38M$ -21.46M
Net Income
$ -15.80B$ -8.96M$ -8.69M$ -9.38M$ -21.46M
Per Share Metrics
Basic EPS
$ -14.80K$ -66.85$ -337.47$ -22.97$ -28.54K
Diluted EPS
$ -14.80K$ -66.85$ -337.47$ -22.97$ -28.54K
Weighted Average Shares Outstanding
 1.07M 133.96K 25.74K 403.88K 1.60K
Weighted Average Shares Outstanding (Diluted)
 1.07M 133.96K 25.74K 403.88K 1.60K
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History